Description:
The HEARTWAVE Alternans Processing System APS by Cambridge Heart Inc. is a high-tech, groundbreaking medical device primarily designed for advanced cardiology diagnostics. It excels in the field of measuring and analyzing microvolt T-wave alternans (MTWA), a subtle beat-to-beat fluctuation in the waveform of the heart's T-wave. The alternation can signify potential vulnerability to seriously life-threatening irregular heart rhythms, also known as ventricular arrhythmia.
The APS is a unique, non-invasive diagnostic tool that unearths previously concealed cardiac markers, providing clinical professionals the ability to identify subjects invisible to ordinary assessment who may be at risk of sudden cardiac arrest. It brings to the table entirely new dimensions to cardiac care, contributing immeasurably to patient prognosis and increasing chances of therapeutic success by enabling early interventions.
So, how does this exceptional system function? The answer lies in its intelligent utilization of MTWA testing. Essentially, the device conducts stress tests to detect MTWA, which typically involves the patient exercising on a treadmill or stationary bicycle. During physical activity, the patient's heart rate is increased under controlled conditions, and the electrical activity is meticulously recorded using the HEARTWAVE Alternans Processing System APS. The acquired information is then digitally processed and analyzed through Cambridge Heart's exceptional algorithms that deeply delve into every microvolt of information.
This device leads the way in the utilization of MTWA testing in both ambulatory settings and hospitals, transforming the approach to cardiac risk stratification across the world. The HEARTWAVE Alternans Processing System APS by Cambridge Heart Inc., without a doubt, is revolutionizing cardiology by enabling the prediction and prevention of catastrophic cardiac incidents!
... Read more